Becker's Healthcare December 13, 2024
Alexandra Murphy

A new report from the Institute for Clinical and Economic Review showed that recent unsupported price hikes for top-selling drugs contributed to $815 million to U.S. medical spending in 2023.

Here are three things to know:

  1. The analysis, which assessed the top 10 drugs with the largest net price increases, found that five of these drugs raised prices without new clinical evidence to justify the increases.
  2. Among the...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Healthcare System, Pharma, Pharma / Biotech, Pricing / Spending, Survey / Study, Trends
How price transparency fails patients and what insurers must reveal next
Trump administration & price transparency: 5 things to know
Where Americans spend the most on health care
Trump’s Executive Order Demands Accountability In Hospital Price Transparency
New Ohio Transparency Pricing Rules for Hospitals Comes with Limits to Targeted Advertising

Share This Article